EDAP TMS reported EUR10.1M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AngioDynamics USD 176.33M 2.52M Sep/2025
Boston Scientific USD 24.93B 934M Jun/2026
EDAP TMS EUR 10.1M 13.22M Mar/2026
Henry Schein USD 3.16B 109M Jun/2026
Medtronic USD 50.07B 1.09B Mar/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Veracyte USD 1.39B 44M Jun/2026